Markers of osteoblast differentiation in fusing and nonfusing cranial sutures

Plastic and Reconstructive Surgery

Volumn 112, Issue 5, 2003, Pages 1328-1335

  Nacamuli, Randall P ^b   Fong, Kenton D ^b   Warren, Stephen M ^b   Fang, Tony D ^b   Song, Hanjoon M ^b   Helms, Jill A ^b   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; OSTEOCALCIN; OSTEOPONTIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CLINICAL GENETICS; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DISEASE ASSOCIATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; IN SITU HYBRIDIZATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; ANIMAL; CYTOLOGY; MALE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CRANIAL SUTURES; IN SITU HYBRIDIZATION; MALE; MICE; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; SIALOGLYCOPROTEINS; TRANSCRIPTION FACTORS;

EID: 0142008694     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000079826.24086.CD     Document Type: Article

References (43)

1. Robin, N. H. Molecular genetic advances in understanding craniosynostosis. Plast. Reconstr. Surg. 103: 1060, 1999.
2. Lajeunie, E., Le Merrer, M., Bonaiti-Pellie, C., Marchac, D., and Renier, D. Genetic study of nonsyndromic coronal craniosynostosis. Am. J. Med. Genet. 55: 500, 1995.
3. Wilkie, A. O. M., Slaney, S. F., Oldridge, M., et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9: 165, 1995.
4. Cohen, M. M., Jr. Transforming growth factor βs and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis. J. Bone Miner. Res. 12: 322, 1997.
5. Cohen, M. M. Immunolocalization of transforming growth factor β1 β2, and β3, and insulin-like growth factor I in premature cranial suture fusion (Discussion). Plast. Reconstr. Surg. 99: 310, 1997.
6. Wilkie, A. O. M., Morriss-Kay, G. M., Jones, E. Y., and Heath, J. K. Functions of fibroblast growth factors and their receptors. Curr. Biol 5: 500, 1995.
7. Jabs, E. W., Xiang, L., Scott, A. D., et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat. Genet. 8: 275, 1994
8. (erratum in Nat. Genet. 9: 451, 1995).
9. Jabs, E. W., Muller, U., Li, X., et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75: 443, 1993.
10. Lomri, A., Lemonnier, J., Hott, M., et al. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J. Clin. Invest. 101: 1310, 1998.
11. Muenke, M., Gripp, K. W., McDonald-McGinn, D. M., et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet. 60: 555, 1997.
12. el Ghouzzi, V., Le Merrer, M., Perrin-Schmitt, F., et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 15: 42, 1997.
13. Howard, T. D., Paznekas, W. A., Green, E. D., et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15: 36, 1997.
14. Ma, L., Golden, S., Wu, L., and Maxson, R. The molecular basis of Boston-type craniosynostosis: The Pro148→His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences. Hum. Mol. Genet. 5: 1915, 1996.
15. Lee, M. S., Lowe, G. N., Strong, D. D., Wergedal, J. E., and Glackin, C. A. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J. Cell. Biochem. 75: 566, 1999.
16. Liu, Y. H., Tang, Z., Kundu, R. K., et al. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans. Dev. Biol. 205: 260, 1999.
17. Zhou, Y. X., Xu, X., Chen, L., et al. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum. Mol. Genet. 9: 2001, 2000.
18. Shevde, N. K., Bendixen, A. C., Maruyama, M., Li, B. L., and Billmire, D. A. Enhanced activity of osteoblast differentiation factor (PEBP2αA2/ CBFa1) in affected sutural osteoblasts from patients with nonsyndromic craniosynostosis. Cleft Palate Craniofac. J. 38: 606, 2001.
19. Lemonnier, J., Hay, E., Delannoy, P., et al. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J. Bone Miner. Res. 16: 832, 2001.
20. Lemonnier, J., Delannoy, P., Hott, M., et al. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent down-regulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp. Cell Res. 256: 158, 2000.
21. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: Implications for suture fusion and patency. J. Bone Miner. Res. 15: 2413, 2000.
22. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747, 1997.
23. Karsenty, G., Ducy, P., Starbuck, M., et al. Cbfa1 as a regulator of osteoblast differentiation and function. Bone 25: 107, 1999.
24. Shirakabe, K., Terasawa, K., Miyama, K., Shibuya, H., and Nishida, E. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 6: 851, 2001.
25. Nomura, S., Wills, A. J., Edwards, D. R., Heath, J. K., and Hogan, B. L. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106: 441, 1988.
26. Desbois, C., Hogue, D. A., and Karsenty, G. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J. Biol. Chem. 269: 1183, 1994.
27. Hauschka, P. V., Lian, J. B., Cole, D. E., and Gundberg, C. M. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol. Rev. 69: 990, 1989.
28. Ducy, P., Desbois, C., Boyce, B., et al. Increased bone formation in osteocalcin-deficient mice. Nature 382: 448, 1996.
29. Albrecht, U., Eichcle, G., Helms, J. A., and Lin, H. Visualization of Gene Expression Patterns by In Situ Hybridization. Boca Raton, Fla.: CRC Press, 1997.
30. Ferguson, C., Alpern, E., Miclau, T., and Helms, J. A. Does adult fracture repair recapitulate embryonic skeletal formation? Mech. Dev. 87: 57, 1999.
31. Moss, M. L. Fusion of the frontal suture in the rat. Am. J. Anal. 102: 141, 1958.
32. Roth, D. A., Bradley, J. P., Levine, J. P., et al. Studies in cranial suture biology: II. Role of the dura in cranial suture fusion. Plast. Reconstr. Surg. 97: 693, 1996.
33. Bradley, J. P., Levine, J. P., Roth, D. A., McCarthy, J. G., and Longaker, M. T. Studies in cranial suture biology: IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse. Plast. Reconstr. Surg. 98: 1039, 1996.
34. Bradley, J. P., Levine J. P., McCarthy, J. G., and Longaker, M. T. Studies in cranial suture biology: Regional dura mater determines in vitro cranial suture fusion. Plast. Reconstr. Surg. 100: 1091, 1997.
35. Mehrara, B. J., Mackool, R. J., McCarthy, J. G., Gittes, G. K., and Longaker, M. T. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast. Reconstr. Surg. 102: 1805, 1998.
36. Most, D., Levine, J. P., Chang, J., et al. Studies in cranial suture biology: Up-regulation of transforming growth factor-β1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast. Reconstr. Surg. 101: 1431, 1998.
37. Fong, K. D., Warren, S. M., Loboa, E. G., et al. Mechanical strain affects dura mater biological processes: Implications for immature calvarial healing. Plast. Reconstr. Surg. 112: 1312, 2003.
38. Warren, S., Harland, R. M., Brunet, L. J., Economides, A. N., and Longaker, M. T. The BMP antagonist noggin regulates cranial suture fusion. Nature 422: 625, 2003.
39. Iseki, S., Wilkie, A. O., Heath, J. K., et al. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124: 3375, 1997.
40. Iseki, S., Wilkie, A. O., and Morriss-Kay, G. M. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126: 5611, 1999.
41. Folkman, J., Klagsbrun, M., Sasse, J., et al. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am. J. Pathol. 130: 393, 1988.
42. Xiao, G., Cui, Y., Ducy, P., Karsenty, G., and Franceschi, R. T. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: Requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol. Endocrinol. 11: 1103, 1997.
43. Xiao, G., Wang, D., Benson, M. D., Karsenty, G., and Franceschi, R. T. Role of the α2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J. Biol. Chem. 273: 32988, 1998.